Unimedic is a contract manufacturer of liquid pharmaceutical drugs. The company offers rational GMP-manufacturing and control in well-equipped laboratories, taking responsibility for the total manufacturing chain, from the purchase of input materials to the release of the end product.
Latest Unimedic News
Oct 1, 2018
SINGAPORE - Healthway Medical Corporation is divesting its entire stake in the loss-making CLAAS Medical Centre in Singapore for $150,000. Healthway's wholly owned subsidiary Unimedic has entered into a sale and purchase agreement on Sept 30 with Liew Kou Chuen to sell 499,993 shares in CLAAS, which represents Unimedic's entire 99.9 per cent stake. Dr Liew is one of the existing shareholders of CLAAS and holds the remaining 0.1 per cent. CLAAS owns 100 per cent of BCNG, which provides medical aesthetics and wellness treatments under the NeuGlow brand. The loss on disposal is expected to amount to $68,000. Healthway said: "As part of its business optimisation strategy, the management has committed to reviewing the performance of all business units to improve operational efficacy. In line with the group's intent and continual efforts to enhance operations, the group has decided to exit the wellness business through the proposed disposal." The net asset value of CLAAS and BCNG as at June 30 was about $200,000. Topics:
Unimedic Frequently Asked Questions (FAQ)
Where is Unimedic's headquarters?
Unimedic's headquarters is located at Storjordenvägen 2, Matfors.
What is Unimedic's latest funding round?
Unimedic's latest funding round is Acq - Fin.
Who are the investors of Unimedic?
Investors of Unimedic include MedCap.